ANNUAL REPORT - Department of Biotechnology
ANNUAL REPORT - Department of Biotechnology
ANNUAL REPORT - Department of Biotechnology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
An Overview<br />
<strong>Biotechnology</strong> is a set <strong>of</strong> rapidly emerging and far<br />
reaching new technologies with great promise in<br />
areas <strong>of</strong> sustainable food production, nutrition<br />
security, health care and environmental<br />
sustainability. Our vision is to use powerful tools <strong>of</strong><br />
biotechnology to help convert the country's diverse<br />
biological resources to useful products and<br />
processes that are accessible to its masses for<br />
economic development and employment generation.<br />
<strong>Biotechnology</strong> is globally recognized as a rapidly<br />
emerging, complex and far reaching new technology.<br />
<strong>Biotechnology</strong> can, over the next two decades,<br />
deliver the next wave <strong>of</strong> technological change that<br />
can be as radical and pervasive as that brought about<br />
by IT. The recent and continuing advances in life<br />
sciences clearly unfold a scenario energized and<br />
driven by the new tools <strong>of</strong> biotechnology. The<br />
convergence <strong>of</strong> advances in biology genomics,<br />
proteomics, bioinformatics and information<br />
technologies is driving the emergence <strong>of</strong> a new<br />
bioeconomy.During the last five years, biotechnology<br />
industry has been growing at a rate <strong>of</strong> 40% and in<br />
2005-06 exceeded US$ 1.5 billion in turnover.<br />
Though the growth was achieved mainly through<br />
leadership in biogenerics and contract<br />
manufacturing, research leading to innovative<br />
product development did not lag behind. The social<br />
impact <strong>of</strong> such growth is evident from India assuming<br />
a dominant place in vaccine exports, diagnostics,<br />
transgenics (Bt Cotton) and a number <strong>of</strong><br />
biotherapeutics. There is a projection <strong>of</strong> an annual<br />
turnover <strong>of</strong> US $ 10 billion for India by 2010 and a<br />
speculated about 25% annual growth rate between<br />
2010 and 2015.During the year 2006-07, the impetus<br />
has been on programmes <strong>of</strong> national relevance with<br />
special emphasis on strengthening <strong>of</strong> infrastructure,<br />
creation <strong>of</strong> centers <strong>of</strong> excellence, capacity building<br />
and developing mission mode programmes and<br />
public-private partnerships. Over 450 R&D projects<br />
have been supported during the year with<br />
approximately 200 universities and research<br />
laboratories being provided the necessary support in<br />
1<br />
Chapter-1<br />
terms <strong>of</strong> both capacity building and infrastructure<br />
strengthening.In the area <strong>of</strong> health care, new<br />
vaccines and diagnostics have been indigenously<br />
developed and are under clinical trials. A major<br />
initiative has been taken to develop stem cell<br />
research in the country and 6 centres have received<br />
programme support. A road map has been<br />
formulated and city clusters established to forge<br />
interdisciplinary collaboration, crucial to this sector.<br />
Cutting edge research in areas <strong>of</strong> tissue engineering,<br />
bio-medical devices, biomaterials, nanobiotechnology<br />
and RNAi is being supported. A<br />
special initiative for devices and formulation required<br />
for a national programme on maternal, neonatal and<br />
child health has been initiated. In the area <strong>of</strong><br />
agriculture biotechnology the focus is on nutritional<br />
enhancement, increased productivity and<br />
development <strong>of</strong> crops resistant to biotic and abiotic<br />
stresses. Establishing Centres <strong>of</strong> Excellence has<br />
received special attention during the current year to<br />
achieve reengineering <strong>of</strong> certain institutes for greater<br />
innovation and focus. The societal development<br />
programme has received special attention and<br />
benefited more than 20,000 SC/ST population,<br />
women and rural population during the year. The<br />
efforts were focused to create enably circumstances<br />
for increasing access <strong>of</strong> common people to new<br />
technologies and products and promoting the mass<br />
use <strong>of</strong> these technologies for healthcare, nutritional<br />
security, employment generation and environmental<br />
well being.Life science and biotechnology sector is<br />
characterized by dynamic changes in flow <strong>of</strong> new<br />
idea and conception and development <strong>of</strong> new tools<br />
for research. Rapid responses are required to meet<br />
these challenges. A number <strong>of</strong> new initiatives has<br />
been taken up during the year to achieve this goal,<br />
which include increased number <strong>of</strong> Ph.D., post-docs<br />
including overseas fellowships, rapid grants for<br />
young investigators, innovation fellowships etc. A<br />
major success during the current year has been the<br />
launch <strong>of</strong> public/private partnership scheme Small<br />
Business Innovation Research Initiative (SBIRI),<br />
An Overview